<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Type 2 Diabetes Clinical Algorithm</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Lato:wght@400;700;900&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.1/css/all.min.css">
    
    <style>
        /* --- Global Styles & Variables --- */
        :root {
            --primary-color: #005a9c;
            --secondary-color: #007bff;
            --text-dark: #343a40;
            --text-light: #6c757d;
            --bg-light: #f8f9fa;
            --bg-white: #ffffff;
            --success-color: #28a745;
            --warning-color: #ffc107;
            --emergency-color: #dc3545;
            --info-color: #17a2b8;
            --border-color: #dee2e6;
            --shadow: 0 4px 12px rgba(0, 0, 0, 0.08);
            --border-radius: 8px;
        }

        body {
            font-family: 'Lato', sans-serif;
            margin: 0;
            background-color: var(--bg-light);
            color: var(--text-dark);
            line-height: 1.6;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }

        h1, h2, h3 {
            font-weight: 700;
            color: var(--primary-color);
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 900;
            margin-bottom: 0.5rem;
        }

        h2 {
            font-size: 1.8rem;
            border-bottom: 2px solid var(--primary-color);
            padding-bottom: 10px;
            margin-bottom: 20px;
            display: flex;
            align-items: center;
        }

        h3 {
            font-size: 1.3rem;
            color: var(--text-dark);
        }

        ul, ol {
            padding-left: 20px;
        }

        li {
            margin-bottom: 8px;
        }

        .icon {
            margin-right: 12px;
            font-size: 1.6rem;
        }

        /* --- Header --- */
        header {
            text-align: center;
            margin-bottom: 40px;
        }

        .subtitle {
            font-size: 1.2rem;
            color: var(--text-light);
            max-width: 600px;
            margin: 0 auto;
        }

        /* --- Card Layout --- */
        .card {
            background: var(--bg-white);
            border-radius: var(--border-radius);
            box-shadow: var(--shadow);
            padding: 25px 30px;
            margin-bottom: 30px;
            border: 1px solid var(--border-color);
        }

        /* --- Section Specific Styles --- */

        /* Diagnosis Section */
        #diagnosis .content-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
        }

        .badge {
            display: inline-block;
            padding: 4px 10px;
            font-size: 0.9em;
            font-weight: 700;
            border-radius: 12px;
            background-color: var(--secondary-color);
            color: white;
        }

        .badge.success { background-color: var(--success-color); }
        .badge.warning { background-color: var(--warning-color); color: var(--text-dark); }
        .target-list li { list-style: none; margin-left: -20px; }

        /* Pharmacological Algorithm */
        .flowchart {
            display: flex;
            flex-direction: column;
            align-items: center;
            text-align: center;
        }

        .flow-step {
            background-color: #f0f7ff;
            border: 1px solid #b3d7ff;
            padding: 20px;
            border-radius: var(--border-radius);
            width: 90%;
            max-width: 700px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }

        .flow-step.decision {
            background-color: #fff9e6;
            border-color: #ffe699;
        }

        .flow-step h3 {
            margin-top: 0;
        }

        .flow-step ul {
            list-style: none;
            padding: 0;
            text-align: left;
        }

        .flow-step li {
            background: #e9ecef;
            padding: 8px 12px;
            border-radius: 4px;
            margin-bottom: 8px;
        }

        .flow-arrow {
            font-size: 2rem;
            color: var(--primary-color);
            margin: 10px 0;
            font-weight: bold;
        }

        .drug-options {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            justify-content: center;
            margin-top: 15px;
        }

        .drug-class {
            padding: 6px 12px;
            border-radius: 15px;
            font-weight: 700;
            color: white;
            font-size: 0.9rem;
        }

        .drug-class.sglt2 { background-color: #28a745; }
        .drug-class.dpp4 { background-color: #17a2b8; }
        .drug-class.pio { background-color: #fd7e14; }
        .drug-class.sulf { background-color: #6f42c1; }
        .drug-class.glp1 { background-color: #d63384; }

        /* Annual Review */
        .circle-of-care {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(150px, 1fr));
            gap: 20px;
            text-align: center;
        }

        .care-item {
            background: var(--bg-light);
            padding: 20px;
            border-radius: var(--border-radius);
            border: 1px solid var(--border-color);
            transition: transform 0.2s, box-shadow 0.2s;
        }

        .care-item:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 16px rgba(0,0,0,0.1);
        }

        .care-item i {
            font-size: 2.5rem;
            color: var(--secondary-color);
            margin-bottom: 10px;
        }

        .care-item h4 {
            margin: 10px 0 5px 0;
            font-size: 1.1rem;
        }

        .care-item p {
            font-size: 0.9rem;
            color: var(--text-light);
            margin: 0;
        }

        /* Key Considerations */
        #key-considerations h2 {
           border-bottom: 2px solid var(--emergency-color);
           color: var(--emergency-color);
        }
        
        .cards-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
        }

        .warning-card, .emergency-card, .info-card {
            border-left: 5px solid;
        }

        .warning-card { border-color: var(--warning-color); }
        .warning-card h3 { color: #856404; }

        .emergency-card { border-color: var(--emergency-color); }
        .emergency-card h3 { color: var(--emergency-color); }

        .info-card { border-color: var(--info-color); }
        .info-card h3 { color: var(--info-color); }

        .sadmans-list {
            list-style: none;
            padding: 0;
        }
        .sadmans-list li {
            font-size: 1.1rem;
        }

        .action-call {
            background-color: var(--emergency-color);
            color: white;
            text-align: center;
            padding: 12px;
            font-weight: 700;
            border-radius: 4px;
            margin-top: 20px;
        }

        /* --- Footer --- */
        footer {
            text-align: center;
            margin-top: 40px;
            padding: 20px;
            color: var(--text-light);
            font-size: 0.9rem;
        }

        /* --- Responsive Design --- */
        @media (max-width: 768px) {
            h1 { font-size: 2rem; }
            #diagnosis .content-grid {
                grid-template-columns: 1fr;
            }
            .flow-step { width: 100%; }
            .circle-of-care {
                grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
            }
        }
    </style>
</head>
<body>

    <div class="container">
        <header>
            <h1>Type 2 Diabetes: A Clinical Algorithm for Primary Care</h1>
            <p class="subtitle">A one-page reference for fast decision-making during patient consultations.</p>
        </header>

        <main>
            <!-- Section 1: Diagnosis & Initial Management -->
            <section id="diagnosis" class="card">
                <h2><i class="fas fa-stethoscope icon"></i>1. Diagnosis & Initial Management</h2>
                <div class="content-grid">
                    <div>
                        <h3>Suspect T2DM If:</h3>
                        <ul>
                            <li><strong>Symptoms:</strong> Polydipsia, polyuria, weight loss, blurred vision.</li>
                            <li><strong>Risk Factors:</strong> Obesity, family history, ethnicity, history of gestational diabetes.</li>
                        </ul>
                        <h3>Confirm Diagnosis:</h3>
                        <ul>
                            <li>HbA1c &ge; <span class="badge">48 mmol/mol (6.5%)</span></li>
                            <li>Fasting Glucose &ge; <span class="badge">7.0 mmol/L</span></li>
                            <li>Random Glucose &ge; <span class="badge">11.1 mmol/L</span> (with symptoms)</li>
                        </ul>
                        <p><small><em>If asymptomatic, two separate abnormal readings are required.</em></small></p>
                    </div>
                    <div>
                        <h3>Immediate Actions:</h3>
                        <ol>
                            <li>Refer to Structured Education (e.g., DESMOND).</li>
                            <li>Emphasise Lifestyle Modification (Diet, exercise, weight loss).</li>
                            <li>Set Initial HbA1c Target:
                                <ul class="target-list">
                                    <li><span class="badge success">48 mmol/mol (6.5%)</span> for lifestyle/Metformin only.</li>
                                    <li><span class="badge warning">53 mmol/mol (7.0%)</span> if on drugs causing hypoglycaemia.</li>
                                </ul>
                            </li>
                        </ol>
                    </div>
                </div>
            </section>

            <!-- Section 2: Pharmacological Treatment -->
            <section id="pharma-algorithm" class="card">
                <h2><i class="fas fa-pills icon"></i>2. Pharmacological Treatment Algorithm</h2>
                <div class="flowchart">
                    <div class="flow-step">
                        <h3>Step 1: First-Line Therapy</h3>
                        <p>Offer <strong>Standard-Release Metformin</strong>.</p>
                        <p><small>If contraindicated, consider DPP-4i, Pioglitazone, Sulfonylurea, or SGLT-2i.</small></p>
                    </div>
                    <div class="flow-arrow">&darr;</div>
                    <div class="flow-step decision">
                        <h3>Step 2: Assess CV & Renal Risk</h3>
                        <ul>
                            <li><strong>Established ASCVD / Heart Failure?</strong> &rarr; Add <span class="drug-class sglt2">SGLT-2 inhibitor</span></li>
                            <li><strong>High ASCVD Risk?</strong> &rarr; Consider adding <span class="drug-class sglt2">SGLT-2 inhibitor</span></li>
                            <li><strong>CKD?</strong> &rarr; Add <span class="drug-class sglt2">SGLT-2 inhibitor</span> (if eGFR criteria met)</li>
                        </ul>
                    </div>
                    <div class="flow-arrow">&darr;</div>
                    <div class="flow-step">
                         <h3>Step 3: Dual Therapy</h3>
                         <p>If HbA1c &ge; <span class="badge warning">58 mmol/mol</span>, aim for <span class="badge success">53 mmol/mol</span>. Add one:</p>
                        <div class="drug-options">
                            <span class="drug-class dpp4">DPP-4i</span>
                            <span class="drug-class pio">Pioglitazone</span>
                            <span class="drug-class sulf">Sulfonylurea</span>
                            <span class="drug-class sglt2">SGLT-2i</span>
                        </div>
                    </div>
                    <div class="flow-arrow">&darr;</div>
                     <div class="flow-step">
                        <h3>Step 4: Triple Therapy</h3>
                        <p>If dual therapy fails, add a third agent from the list above OR consider starting <strong>insulin</strong>.</p>
                    </div>
                     <div class="flow-arrow">&darr;</div>
                    <div class="flow-step">
                        <h3>Step 5: Further Intensification</h3>
                        <p>If triple therapy fails, consider:</p>
                        <ul>
                            <li><span class="drug-class glp1">GLP-1 RA</span> (if BMI criteria met)</li>
                            <li>Start or intensify <strong>insulin therapy</strong>.</li>
                        </ul>
                    </div>
                </div>
            </section>

            <!-- Section 3: Annual Review -->
            <section id="annual-review" class="card">
                <h2><i class="fas fa-sync-alt icon"></i>3. Annual Review: The Circle of Care</h2>
                <div class="circle-of-care">
                    <div class="care-item">
                        <i class="fas fa-vial"></i>
                        <h4>HbA1c</h4>
                        <p>6-monthly when stable</p>
                    </div>
                    <div class="care-item">
                        <i class="fas fa-heartbeat"></i>
                        <h4>Blood Pressure</h4>
                        <p>Target &lt;140/90 mmHg</p>
                    </div>
                    <div class="care-item">
                        <i class="fas fa-kidneys"></i>
                        <h4>Kidney Function</h4>
                        <p>Check eGFR & ACR</p>
                    </div>
                    <div class="care-item">
                        <i class="fas fa-chart-line"></i>
                        <h4>CVD Risk</h4>
                        <p>Atorvastatin 20mg (Primary) / 80mg (Secondary)</p>
                    </div>
                    <div class="care-item">
                        <i class="fas fa-eye"></i>
                        <h4>Eye Screening</h4>
                        <p>Refer for Retinopathy Screen</p>
                    </div>
                    <div class="care-item">
                        <i class="fas fa-shoe-prints"></i>
                        <h4>Foot Care</h4>
                        <p>Examine pulses & sensation</p>
                    </div>
                </div>
            </section>

            <!-- Section 4: Key Management Considerations -->
            <section id="key-considerations">
                 <h2><i class="fas fa-exclamation-triangle icon"></i>4. Key Management Considerations</h2>
                <div class="cards-container">
                    <div class="card warning-card">
                        <h3><i class="fas fa-bed"></i>Sick Day Rules (SADMANS)</h3>
                        <p>During acute illness, advise patients to <strong>temporarily STOP</strong>:</p>
                        <ul class="sadmans-list">
                             <li><strong>S</strong> - SGLT-2 inhibitors</li>
                            <li><strong>A</strong> - ACE inhibitors / ARBs</li>
                            <li><strong>D</strong> - Diuretics</li>
                            <li><strong>M</strong> - Metformin</li>
                            <li><strong>A</strong> - Angiotensin II receptor blockers (ARBs)</li>
                            <li><strong>N</strong> - NSAIDs</li>
                            <li><strong>S</strong> - Sulfonylureas (if not eating)</li>
                        </ul>
                        <p><strong>Key Advice:</strong> Maintain fluids, monitor glucose. <strong>NEVER stop insulin.</strong></p>
                    </div>
                    <div class="card emergency-card">
                        <h3><i class="fas fa-ambulance"></i>Hyperglycaemic Emergencies</h3>
                        <p>Suspect DKA/HHS in any unwell diabetic patient. Act fast.</p>
                        <ul>
                            <li><strong>DKA:</strong> Ketones present, can occur with near-normal glucose (esp. with SGLT-2i).</li>
                            <li><strong>HHS:</strong> Severe hyperglycemia (&gt;30 mmol/L), dehydration, confusion, no significant ketones.</li>
                        </ul>
                        <div class="action-call">EMERGENCY HOSPITAL ADMISSION</div>
                    </div>
                     <div class="card info-card">
                        <h3><i class="fas fa-tint"></i>Hypoglycaemia (&lt;4.0 mmol/L)</h3>
                        <p><strong>Main Risk:</strong> Insulin and Sulfonylureas.</p>
                        <p><strong>Treatment:</strong></p>
                        <ol>
                           <li>Give 15-20g of fast-acting carbohydrate.</li>
                           <li>Re-check blood glucose in 15 minutes.</li>
                           <li>Repeat if necessary.</li>
                        </ol>
                    </div>
                </div>
            </section>
        </main>

        <footer>
            <p>This algorithm is a condensed summary for quick reference and does not replace full clinical guidelines.</p>
        </footer>
    </div>

</body>
</html>